Aeglea Biotherapeutics shares owned by TD Asset Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by TD Asset Management
from 13F filings
Historical chart of TD Asset Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aeglea Biotherapeutics by TD Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $1.5M | 65k | 23.28 |
2024-09-30 | $1.5M | 53k | 28.49 |
2024-06-30 | $827k | 35k | 23.51 |
2024-03-31 | $2.3M | 61k | 37.93 |